Search

Search Funnelback University

Search powered by Funnelback
61 - 77 of 77 search results for `including lupus`
  1. Fully-matching results

  2. https://www.phpc.cam.ac.uk/pcu/tag/miranda-van-emmenis/feed/

    https://www.phpc.cam.ac.uk/pcu/tag/miranda-van-emmenis/feed/
    19 Feb 2024: of Cambridge to study the experiences of patients with lupus and related diseases. ... The team used mixed methods including surveys, qualitative interviews with patients and healthcare providers, and ethnographic analyses of LUPUS UK forum posts./h4 h4Mo
  3. Cambridge Enterprise invests in PredictImmune – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-invests-in-predictimmune/
    Thumbnail for Cambridge Enterprise invests in PredictImmune – Cambridge Enterprise 22 Feb 2023: Predictimmune will develop similar predictive tests for other significant diseases, which fall into the same immune-mediated category, including lupus, multiple sclerosis, diabetes mellitus, rheumatoid arthritis and transplantation complications.
  4. Potential new therapeutic target for inflammatory diseases | MRC…

    https://www.mrc-mbu.cam.ac.uk/news/potential-new-therapeutic-target-inflammatory-diseases
    23 Feb 2024: Macrophages are a frontline inflammatory cell type that are implicated in a range of diseases including Lupus, Arthritis, Sepsis and Covid-19. ... This study is a collaboration involving researchers of eight Universities, including the Murphy Group at
  5. ‘But you don’t look sick’: A qualitative analysis of the LUPUS UK…

    https://www.phpc.cam.ac.uk/pcu/but-you-dont-look-sick-a-qualitative-analysis-of-the-lupus-uk-forum/
    23 Feb 2024: Site Search. ‘But you don’t look sick’: A qualitative analysis of the LUPUS UK forum. ... sick’: a qualitative analysis of the LUPUS UK online forum, published online, Rheumatology International, 27 October 2020.
  6. Relationships with clinicians and adverse medical experiences affect…

    https://www.phpc.cam.ac.uk/pcu/relationships-with-clinicians-and-adverse-medical-experiences-affect-medication-adherence-amongst-lupus-patients/
    23 Feb 2024: People with incurable systemic auto-immune conditions, including lupus, often need lifelong medications to slow or stop the progression of the disease. ... Often lupus patients have had stressful healthcare related experiences, including long diagnostic
  7. https://www.phpc.cam.ac.uk/pcu/tag/patient-and-public-involvement/feed…

    https://www.phpc.cam.ac.uk/pcu/tag/patient-and-public-involvement/feed/
    19 Feb 2024: of Cambridge to study the experiences of patients with lupus and related diseases. ... The team used mixed methods including surveys, qualitative interviews with patients and healthcare providers, and ethnographic analyses of LUPUS UK forum posts./h4 h4Mo
  8. History Of Technology Transfer - MRC Laboratory of Molecular Biology

    https://www2.mrc-lmb.cam.ac.uk/research/technology-transfer/history-of-technology-transfer/
    Thumbnail for History Of Technology Transfer - MRC Laboratory of Molecular Biology 21 Jul 2023: Today, the approach taken in commercialising an invention is likely to depend on a number of factors including the nature of the discovery and the maturity of the marketplace. ... Other antibodies followed, including BENLYSTA, which promises to be the
  9. Human Antibodies developed for Treatment of Lupus and Anthrax - MRC…

    https://www2.mrc-lmb.cam.ac.uk/human-antibodies-developed-for-treatment-of-lupus-and-anthrax/
    Thumbnail for Human Antibodies developed for Treatment of Lupus and Anthrax - MRC Laboratory of Molecular Biology 31 Jul 2009: If approved, belimumab would become the first new drug treatment for lupus in 50 years. ... Approximately five million people worldwide, including about 1.5 million in the United States, suffer from various forms of lupus, including systemic lupus
  10. Cambridge spin-out PredictImmune closes Series B, raising £10m –…

    https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-predictimmune-closes-series-b-raising-10m/
    Thumbnail for Cambridge spin-out PredictImmune closes Series B, raising £10m – Cambridge Enterprise 22 Feb 2023: areas including systemic lupus erythematosus (SLE).
  11. 'Inconsistent' shielding guidance increases fears for…

    https://www.phpc.cam.ac.uk/pcu/inconsistent-shielding-guidance-increases-fears-for-vulnerable-lupus-patients-during-the-pandemic/
    23 Feb 2024: Site Search. ‘Inconsistent’ shielding guidance increases fears for vulnerable lupus patients during the pandemic. ... wide disparity in the communication and level of support received by lupus and related disease patients.
  12. News - Page 23 of 89 - Primary Care Unit

    https://www.phpc.cam.ac.uk/pcu/news-about-research-and-activities-at-the-primary-care-unit-research-news-medical-education-news-applied-clinical-research-news-primary-care-research-news/page/23/
    During the 2020 pandemic, patients with systemic autoimmune rheumatic diseases (including lupus) expressed a strong sense of being endangered from both the virus and the redeployment of medical resources.
  13. MNRAS 000, 1–11 (2020) Preprint 26November 2020 Compiled…

    https://people.ast.cam.ac.uk/~wyatt/zcac20.pdf
    26 Nov 2020: Sz 108. -0.50.00.5-0.5. 0.0. 0.5. 1.0. IRAS 16054-3857. Figure 1. A gallery including all the detected multiple systems of the Lupus sample. ... Only 4 multiple systems in Lupus have all the componentsdetected also by ALMA.
  14. News - Page 17 of 89 - Primary Care Unit

    https://www.phpc.cam.ac.uk/pcu/news-about-research-and-activities-at-the-primary-care-unit-research-news-medical-education-news-applied-clinical-research-news-primary-care-research-news/page/17/
    Scenarios where […]. Filed Under:Tagged With:July 19, 2021. New research highlights the impact of current and past medical interactions – especially adverse experiences – on medication adherence amongst lupus patients and indicates ... People with
  15. ADVANCING RESEARCH IN RENAL AUTOIMMUNITY A COLLABORATIVE SYMPOSIUM…

    https://otr.medschl.cam.ac.uk/files/8_emi_autoimmunity_schedule_230120.pdf
    24 Nov 2022: Single and multi-centre clinical trials have been performed in ANCA vasculitis, Behçet’s syndrome and lupus nephritis including the evaluation of mycophenolate mofetil, alemtuzumab, infliximab, adalimumab, rituximab and deoxyspergualin.
  16. Cancer Drug Discovery and Development TUESDAY, 5TH MARCH 2019 ...

    https://otr.medschl.cam.ac.uk/files/2_emi-oncology-training-event-schedule-_final.pdf
    24 Nov 2022: He transitioned into clinical trials in 2012, where he has worked in various areas including immuno-inflammatory: Lupus, Idiopathic thrombocytopenic purpura (ITP), Respiratory: COPD, Transplant: Kidney. ... Robert has made significant contributions in
  17. Consultation Document on Schema Assumptions

    https://www.jbs.cam.ac.uk/wp-content/uploads/2020/08/crs-geac-multiline-data-schema-consultation-document-phase-two-v0.9.pdf
    9 Jul 2023: 6.2. Policy Contractual and Financial Structure Contract information about the policy is captured, including financial structure, dates of coverage inception and expiration, and the legal jurisdiction in which claims or ... p) Kidney disease, renal
  18. Discovery and development of treatments for immunological diseases

    https://www.ubs.admin.cam.ac.uk/system/files/public/discovery_and_development_of_treatments_for_immunological_diseases_non-technical_summary_redacted.pdf
    29 Apr 2024: Why is it important to undertake this work? Despite decades of research, millions of people live with serious immune mediated disease such as colitis, arthritis, systemic lupus erythematosus (SLE) and atopic ... Other autoimmune diseases such as lupus

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.